ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,064.20
      0.91%
      US Tech 100
      17,178.00
      1.88%
      Dow Jones
      38,225.66
      0.85%
      Brent Oil
      83.815
      0.22%
      Bitcoin
      59,607.99
      0.82%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Vir Biotechnology Inc (VIR)

      7. Vir Biotechnology Inc (VIR) News

      VIR

      Vir Biotechnology (VIR)

      Vir Biotechnology Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:VIR
      DateTimeSourceHeadlineSymbolCompany
      2:07PMiHub NewswireFeaturedNanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon
      05/02/20244:05PMBusiness WireVir Biotechnology Provides Corporate Update and Reports First Quarter 2024 Financial ResultsNASDAQ:VIRVir Biotechnology Inc
      04/30/20244:05PMBusiness WireVir Biotechnology to Participate in the BofA Securities Healthcare Conference 2024NASDAQ:VIRVir Biotechnology Inc
      04/18/20248:00AMBusiness WireVir Biotechnology Announces Nomination of Norbert Bischofberger, Ph.D. and Ramy Farid, Ph.D. to its Board of DirectorsNASDAQ:VIRVir Biotechnology Inc
      04/11/20244:30PMBusiness WireVir Biotechnology to Provide Business Update and Report First Quarter 2024 Financial Results on May 2, 2024NASDAQ:VIRVir Biotechnology Inc
      03/05/20248:05AMBusiness WireVir Biotechnology Completes Enrollment of Phase 2 Chronic Hepatitis Delta SOLSTICE Trial Ahead of ScheduleNASDAQ:VIRVir Biotechnology Inc
      02/26/20247:34PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VIRVir Biotechnology Inc
      02/26/20247:32PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VIRVir Biotechnology Inc
      02/26/20247:32PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VIRVir Biotechnology Inc
      02/26/20247:31PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VIRVir Biotechnology Inc
      02/26/20244:27PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:VIRVir Biotechnology Inc
      02/26/20244:10PMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:VIRVir Biotechnology Inc
      02/23/20248:05AMBusiness WireVir Biotechnology to Participate in Upcoming Investor Healthcare ConferencesNASDAQ:VIRVir Biotechnology Inc
      02/22/20244:12PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VIRVir Biotechnology Inc
      02/22/20244:05PMBusiness WireVir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:VIRVir Biotechnology Inc
      02/20/20244:33PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VIRVir Biotechnology Inc
      02/20/20244:30PMBusiness WireVir Biotechnology Announces Dr. Phil Pang Will Step Down as Chief Medical OfficerNASDAQ:VIRVir Biotechnology Inc
      02/16/20246:56PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VIRVir Biotechnology Inc
      02/13/20245:00PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:VIRVir Biotechnology Inc
      02/01/20244:05PMBusiness WireVir Biotechnology to Provide Business Update and Report Fourth Quarter 2023 Financial Results on February 22, 2024NASDAQ:VIRVir Biotechnology Inc
      01/03/20242:47PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VIRVir Biotechnology Inc
      12/14/20235:59AMIH Market NewsApple Stocks Reach Record, Adobe Faces Stock Drops, Berkshire Hathaway Increases Stake in OXY, and MoreNASDAQ:VIRVir Biotechnology Inc
      12/13/20234:06PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VIRVir Biotechnology Inc
      12/13/20234:05PMBusiness WireVir Biotechnology Announces Strategic Steps to Reduce Operating Expenses and Focus Investment on Areas with Highest Potential for Value CreationNASDAQ:VIRVir Biotechnology Inc
      12/06/20234:05PMBusiness WireVir Biotechnology to Present at J.P. Morgan 2024 42nd Annual Healthcare ConferenceNASDAQ:VIRVir Biotechnology Inc
      11/13/20238:00AMBusiness WireVir Biotechnology to Present New Data from Its Ongoing Phase 2 Chronic Hepatitis Delta and B Trials Today at AASLD’s The Liver Meeting® 2023NASDAQ:VIRVir Biotechnology Inc
      11/10/20238:00AMBusiness WireVir Biotechnology to Present Late-Breaking Data from Its Ongoing Phase 2 Chronic Hepatitis B and Delta Trials at AASLD’s The Liver Meeting® 2023NASDAQ:VIRVir Biotechnology Inc
      11/08/20238:05AMBusiness WireVir Biotechnology Ranked the Fastest-Growing Company in North America on the 2023 Deloitte Technology Fast 500™NASDAQ:VIRVir Biotechnology Inc
      11/03/20234:37PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VIRVir Biotechnology Inc
      11/03/20234:33PMEdgar (US Regulatory)Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuersNASDAQ:VIRVir Biotechnology Inc
       Showing the most relevant articles for your search:NASDAQ:VIR